Menu
GWAS Study

Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification.

Kavousi M, Bos MM, Barnes HJ et al.

37770635 PubMed ID
GWAS Study Type
36720 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KM
Kavousi M
BM
Bos MM
BH
Barnes HJ
LC
Lino Cardenas CL
WD
Wong D
LH
Lu H
HC
Hodonsky CJ
LL
Landsmeer LPL
TA
Turner AW
KM
Kho M
HN
Hasbani NR
DV
de Vries PS
BD
Bowden DW
CS
Chopade S
DJ
Deelen J
BE
Benavente ED
GX
Guo X
HE
Hofer E
HS
Hwang SJ
LS
Lutz SM
LL
Lyytikäinen LP
SL
Slenders L
SA
Smith AV
SM
Stanislawski MA
VS
van Setten J
WQ
Wong Q
YL
Yanek LR
BD
Becker DM
BM
Beekman M
BM
Budoff MJ
FM
Feitosa MF
FC
Finan C
HA
Hilliard AT
KS
Kardia SLR
KJ
Kovacic JC
KB
Kral BG
LC
Langefeld CD
LL
Launer LJ
MS
Malik S
HF
Hoesein FAAM
MM
Mokry M
SR
Schmidt R
SJ
Smith JA
TK
Taylor KD
TJ
Terry JG
VD
van der Grond J
VM
van Meurs J
VR
Vliegenthart R
XJ
Xu J
YK
Young KA
ZN
Zilhão NR
ZR
Zweiker R
AT
Assimes TL
BL
Becker LC
BD
Bos D
CJ
Carr JJ
CL
Cupples LA
DK
de Kleijn DPV
DW
de Winther M
DR
den Ruijter HM
FM
Fornage M
FB
Freedman BI
GV
Gudnason V
HA
Hingorani AD
HJ
Hokanson JE
IM
Ikram MA
II
Išgum I
JD
Jacobs DR
KM
Kähönen M
LL
Lange LA
LT
Lehtimäki T
PG
Pasterkamp G
RO
Raitakari OT
SH
Schmidt H
SP
Slagboom PE
UA
Uitterlinden AG
VM
Vernooij MW
BJ
Bis JC
FN
Franceschini N
PB
Psaty BM
PW
Post WS
RJ
Rotter JI
BJ
Björkegren JLM
OC
O'Donnell CJ
BL
Bielak LF
PP
Peyser PA
MR
Malhotra R
VD
van der Laan SW
MC
Miller CL
Chapter II

Abstract

Summary of the research findings

Coronary artery calcification (CAC), a measure of subclinical atherosclerosis, predicts future symptomatic coronary artery disease (CAD). Identifying genetic risk factors for CAC may point to new therapeutic avenues for prevention. Currently, there are only four known risk loci for CAC identified from genome-wide association studies (GWAS) in the general population. Here we conducted the largest multi-ancestry GWAS meta-analysis of CAC to date, which comprised 26,909 individuals of European ancestry and 8,867 individuals of African ancestry. We identified 11 independent risk loci, of which eight were new for CAC and five had not been reported for CAD. These new CAC loci are related to bone mineralization, phosphate catabolism and hormone metabolic pathways. Several new loci harbor candidate causal genes supported by multiple lines of functional evidence and are regulators of smooth muscle cell-mediated calcification ex vivo and in vitro. Together, these findings help refine the genetic architecture of CAC and extend our understanding of the biological and potential druggable pathways underlying CAC.

28,655 European ancestry individuals, 8,065 African American individuals

Chapter III

Study Statistics

Key metrics and study information

36720
Total Participants
GWAS
Study Type
No
Replicated
European, African American or Afro-Caribbean
Ancestry
Austria, Netherlands, U.S., Belgium, Finland, Iceland
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.